Further evidence for glutaminolysis was found in PAH patients with hereditary BMPR2 mutation whom exhibited enhanced blood levels of glutamine, glutaminolysis and exhibited hyperproliferative phenotype in their ECs. Here, BMPR2 is linked to pulmonary arterial hypertension.